StockData
Cellyan Biotechnology Co., Ltd logo

Cellyan Biotechnology Co., Ltd (HKPD) stock

HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Aug 7, 2026Score 3/30
$1.52−0.09 (-5.30%)

Close on Nov 17, 2026Market cap $24.93MP/E –Yield –

Cellyan Biotechnology operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2026 it was -17.8%, against -11.2% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2026Mar 31, 2026-17.8%−6.5
FY2025Mar 31, 2025-11.2%+0.5
FY2024Mar 31, 2024-11.7%+2.6
FY2023Mar 31, 2023-14.3%–

More Cellyan Biotechnology figures

See a number that looks wrong?